
doi: 10.1002/ibd.21911
pmid: 22021180
Restorative proctocolectomy with ileal-pouch anal anastomosis (RPC) is the operation of choice for ulcerative colitis (UC) patients requiring surgery. It is also used for patients with familial adenomatous polyposis (FAP). Pouchitis accounts for 10% of pouch failures. It is an idiopathic inflammatory condition that may occur in up to 50% of patients after RPC for UC. It is rarely seen in FAP patients after RPC. The etiology of pouchitis remains unclear. An overlap with UC is suggested by the frequency with which pouchitis affects patients with UC compared with FAP patients. There is significant clinical evidence implicating bacteria in the pathogenesis of pouchitis. Studies using culture and molecular methods demonstrate a dysbiosis of the pouch microbiota in pouchitis. Risk factors, genetic associations, and serological markers of pouchitis suggest that the interactions between the host immune responses and the pouch microbiota underlie the etiology of this idiopathic inflammatory condition. Here we present a detailed review of the data focusing on the pouch microbiota and the immune responses that support this hypothesis. We also discuss the contribution of luminal metabolic factors and the epithelial membrane in the etiology of this inflammatory process. The ileoanal pouch offers a unique opportunity to study the inter-relationships between the gut microbiota and host immune responses from before the onset of disease. For this reason the study of pouchitis could serve as a human model that significantly enhances our understanding of inflammatory bowel diseases in general.
etiology, Proctocolectomy, Restorative, 610, PRIMARY SCLEROSING CHOLANGITIS, Pouchitis, PLACEBO-CONTROLLED TRIAL, Inflammatory Bowel Diseases, inflammatory bowel diseases, SMALL-INTESTINAL PERMEABILITY, ULCERATIVE-COLITIS PATIENTS, LACTOBACILLUS-RHAMNOSUS GG, FAMILIAL ADENOMATOUS POLYPOSIS, Risk Factors, ANTINEUTROPHIL CYTOPLASMIC ANTIBODY, Humans, PELVIC ILEAL POUCHES, PROBIOTIC THERAPY VSLNUMBER-3, pouchitis
etiology, Proctocolectomy, Restorative, 610, PRIMARY SCLEROSING CHOLANGITIS, Pouchitis, PLACEBO-CONTROLLED TRIAL, Inflammatory Bowel Diseases, inflammatory bowel diseases, SMALL-INTESTINAL PERMEABILITY, ULCERATIVE-COLITIS PATIENTS, LACTOBACILLUS-RHAMNOSUS GG, FAMILIAL ADENOMATOUS POLYPOSIS, Risk Factors, ANTINEUTROPHIL CYTOPLASMIC ANTIBODY, Humans, PELVIC ILEAL POUCHES, PROBIOTIC THERAPY VSLNUMBER-3, pouchitis
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 71 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
